nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—CYP2C9—brain cancer	0.608	1	CbGaD
Nateglinide—CYP2D6—Lomustine—brain cancer	0.0598	0.23	CbGbCtD
Nateglinide—CYP2D6—Hydroxyurea—brain cancer	0.0453	0.174	CbGbCtD
Nateglinide—CYP3A4—Temozolomide—brain cancer	0.0447	0.172	CbGbCtD
Nateglinide—PTGS1—Etoposide—brain cancer	0.0393	0.151	CbGbCtD
Nateglinide—CYP3A4—Lomustine—brain cancer	0.038	0.146	CbGbCtD
Nateglinide—CYP3A5—Etoposide—brain cancer	0.0236	0.0907	CbGbCtD
Nateglinide—CYP3A4—Etoposide—brain cancer	0.00919	0.0354	CbGbCtD
Nateglinide—SLC15A2—choroid plexus—brain cancer	0.0084	0.17	CbGeAlD
Nateglinide—PPARG—Teniposide—Etoposide—brain cancer	0.0029	1	CbGdCrCtD
Nateglinide—Gastrointestinal symptom NOS—Hydroxyurea—brain cancer	0.00221	0.0459	CcSEcCtD
Nateglinide—Osteoarthritis—Lomustine—brain cancer	0.00192	0.0399	CcSEcCtD
Nateglinide—PPARG—endothelium—brain cancer	0.00169	0.0341	CbGeAlD
Nateglinide—PPARG—blood vessel—brain cancer	0.00156	0.0314	CbGeAlD
Nateglinide—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.00138	0.0285	CcSEcCtD
Nateglinide—SLC16A1—Pyruvate metabolism—BSG—brain cancer	0.00121	0.039	CbGpPWpGaD
Nateglinide—SLC16A1—Basigin interactions—BSG—brain cancer	0.00117	0.0378	CbGpPWpGaD
Nateglinide—ABCC8—brainstem—brain cancer	0.00111	0.0225	CbGeAlD
Nateglinide—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00109	0.0351	CbGpPWpGaD
Nateglinide—Hepatic enzyme increased—Temozolomide—brain cancer	0.00107	0.0223	CcSEcCtD
Nateglinide—PTGS1—ganglion—brain cancer	0.00105	0.0211	CbGeAlD
Nateglinide—Sweating increased—Procarbazine—brain cancer	0.00103	0.0213	CcSEcCtD
Nateglinide—ABCC8—telencephalon—brain cancer	0.000989	0.02	CbGeAlD
Nateglinide—UGT1A9—endocrine gland—brain cancer	0.000968	0.0195	CbGeAlD
Nateglinide—Neuropathy peripheral—Procarbazine—brain cancer	0.000922	0.0191	CcSEcCtD
Nateglinide—Jaundice—Procarbazine—brain cancer	0.000917	0.019	CcSEcCtD
Nateglinide—PTGS1—endothelium—brain cancer	0.000902	0.0182	CbGeAlD
Nateglinide—Sweating—Procarbazine—brain cancer	0.000901	0.0187	CcSEcCtD
Nateglinide—SLC16A1—telencephalon—brain cancer	0.0009	0.0182	CbGeAlD
Nateglinide—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.000889	0.0288	CbGpPWpGaD
Nateglinide—PTGS1—blood vessel—brain cancer	0.000832	0.0168	CbGeAlD
Nateglinide—Injury—Carmustine—brain cancer	0.000831	0.0172	CcSEcCtD
Nateglinide—ABCC8—pituitary gland—brain cancer	0.000805	0.0163	CbGeAlD
Nateglinide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000805	0.026	CbGpPWpGaD
Nateglinide—CYP3A7—endocrine gland—brain cancer	0.000805	0.0163	CbGeAlD
Nateglinide—ABCC4—Ectoderm Differentiation—TSC22D1—brain cancer	0.000791	0.0256	CbGpPWpGaD
Nateglinide—ABCC8—medulla oblongata—brain cancer	0.000777	0.0157	CbGeAlD
Nateglinide—Thirst—Temozolomide—brain cancer	0.000775	0.0161	CcSEcCtD
Nateglinide—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000752	0.0243	CbGpPWpGaD
Nateglinide—SLC16A1—gonad—brain cancer	0.000751	0.0152	CbGeAlD
Nateglinide—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000738	0.0239	CbGpPWpGaD
Nateglinide—SLC16A1—pituitary gland—brain cancer	0.000732	0.0148	CbGeAlD
Nateglinide—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—BSG—brain cancer	0.000729	0.0236	CbGpPWpGaD
Nateglinide—UGT1A9—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000726	0.0235	CbGpPWpGaD
Nateglinide—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000713	0.0148	CcSEcCtD
Nateglinide—ABCC8—midbrain—brain cancer	0.00071	0.0143	CbGeAlD
Nateglinide—SLC16A1—medulla oblongata—brain cancer	0.000707	0.0143	CbGeAlD
Nateglinide—ABCC8—spinal cord—brain cancer	0.000693	0.014	CbGeAlD
Nateglinide—Bortezomib—CYP2C9—brain cancer	0.00069	1	CrCbGaD
Nateglinide—Tremor—Procarbazine—brain cancer	0.000688	0.0143	CcSEcCtD
Nateglinide—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000688	0.0143	CcSEcCtD
Nateglinide—KCNJ11—endocrine gland—brain cancer	0.000677	0.0137	CbGeAlD
Nateglinide—KCNJ11—head—brain cancer	0.000668	0.0135	CbGeAlD
Nateglinide—CYP2D6—hindbrain—brain cancer	0.000652	0.0132	CbGeAlD
Nateglinide—SLC16A1—midbrain—brain cancer	0.000646	0.013	CbGeAlD
Nateglinide—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000643	0.0208	CbGpPWpGaD
Nateglinide—Cough—Procarbazine—brain cancer	0.000641	0.0133	CcSEcCtD
Nateglinide—SLC16A1—spinal cord—brain cancer	0.00063	0.0127	CbGeAlD
Nateglinide—ABCC8—endocrine gland—brain cancer	0.000624	0.0126	CbGeAlD
Nateglinide—Sweating increased—Temozolomide—brain cancer	0.000621	0.0129	CcSEcCtD
Nateglinide—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000618	0.02	CbGpPWpGaD
Nateglinide—ABCC8—head—brain cancer	0.000616	0.0124	CbGeAlD
Nateglinide—Bronchitis—Temozolomide—brain cancer	0.000613	0.0127	CcSEcCtD
Nateglinide—KCNJ11—central nervous system—brain cancer	0.00061	0.0123	CbGeAlD
Nateglinide—Vomiting—Lomustine—brain cancer	0.000601	0.0125	CcSEcCtD
Nateglinide—KCNJ11—cerebellum—brain cancer	0.000596	0.012	CbGeAlD
Nateglinide—SLC15A1—endocrine gland—brain cancer	0.000596	0.012	CbGeAlD
Nateglinide—Upper respiratory tract infection—Temozolomide—brain cancer	0.000593	0.0123	CcSEcCtD
Nateglinide—SLC15A2—telencephalon—brain cancer	0.000591	0.0119	CbGeAlD
Nateglinide—Hyperhidrosis—Procarbazine—brain cancer	0.00058	0.012	CcSEcCtD
Nateglinide—Neuropathy peripheral—Carmustine—brain cancer	0.000577	0.012	CcSEcCtD
Nateglinide—SLC16A1—endocrine gland—brain cancer	0.000567	0.0115	CbGeAlD
Nateglinide—ORM1—spinal cord—brain cancer	0.000566	0.0114	CbGeAlD
Nateglinide—ABCC8—central nervous system—brain cancer	0.000562	0.0114	CbGeAlD
Nateglinide—Nausea—Lomustine—brain cancer	0.000561	0.0116	CcSEcCtD
Nateglinide—SLC16A1—head—brain cancer	0.00056	0.0113	CbGeAlD
Nateglinide—Neuropathy peripheral—Temozolomide—brain cancer	0.000557	0.0116	CcSEcCtD
Nateglinide—ABCC8—cerebellum—brain cancer	0.000549	0.0111	CbGeAlD
Nateglinide—Hepatobiliary disease—Temozolomide—brain cancer	0.000538	0.0112	CcSEcCtD
Nateglinide—Oedema peripheral—Carmustine—brain cancer	0.00052	0.0108	CcSEcCtD
Nateglinide—Fatigue—Procarbazine—brain cancer	0.000517	0.0107	CcSEcCtD
Nateglinide—SLC22A6—brain—brain cancer	0.000513	0.0104	CbGeAlD
Nateglinide—SLC16A1—central nervous system—brain cancer	0.000511	0.0103	CbGeAlD
Nateglinide—ORM1—endocrine gland—brain cancer	0.000509	0.0103	CbGeAlD
Nateglinide—Oedema peripheral—Temozolomide—brain cancer	0.000503	0.0104	CcSEcCtD
Nateglinide—SLC16A1—cerebellum—brain cancer	0.0005	0.0101	CbGeAlD
Nateglinide—Sweating increased—Etoposide—brain cancer	0.000497	0.0103	CcSEcCtD
Nateglinide—Gastrointestinal pain—Procarbazine—brain cancer	0.00049	0.0102	CcSEcCtD
Nateglinide—KCNJ11—brain—brain cancer	0.000484	0.00978	CbGeAlD
Nateglinide—Erythema multiforme—Temozolomide—brain cancer	0.000483	0.01	CcSEcCtD
Nateglinide—SLC15A2—pituitary gland—brain cancer	0.000481	0.00972	CbGeAlD
Nateglinide—Urticaria—Procarbazine—brain cancer	0.000476	0.00988	CcSEcCtD
Nateglinide—PPARG—endocrine gland—brain cancer	0.000476	0.00962	CbGeAlD
Nateglinide—Abdominal pain—Procarbazine—brain cancer	0.000474	0.00983	CcSEcCtD
Nateglinide—PPARG—head—brain cancer	0.00047	0.00949	CbGeAlD
Nateglinide—SLC15A2—medulla oblongata—brain cancer	0.000464	0.00938	CbGeAlD
Nateglinide—Immune system disorder—Temozolomide—brain cancer	0.000461	0.00956	CcSEcCtD
Nateglinide—Malnutrition—Carmustine—brain cancer	0.00046	0.00953	CcSEcCtD
Nateglinide—ORM1—central nervous system—brain cancer	0.000459	0.00927	CbGeAlD
Nateglinide—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000457	0.0148	CbGpPWpGaD
Nateglinide—ABCC8—brain—brain cancer	0.000446	0.00901	CbGeAlD
Nateglinide—Neuropathy peripheral—Etoposide—brain cancer	0.000446	0.00925	CcSEcCtD
Nateglinide—Back pain—Carmustine—brain cancer	0.000445	0.00922	CcSEcCtD
Nateglinide—Malnutrition—Temozolomide—brain cancer	0.000444	0.00921	CcSEcCtD
Nateglinide—Jaundice—Etoposide—brain cancer	0.000443	0.0092	CcSEcCtD
Nateglinide—Hypersensitivity—Procarbazine—brain cancer	0.000442	0.00916	CcSEcCtD
Nateglinide—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000441	0.0143	CbGpPWpGaD
Nateglinide—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00044	0.0142	CbGpPWpGaD
Nateglinide—PPARG—Regulation of retinoblastoma protein—SMARCB1—brain cancer	0.000433	0.014	CbGpPWpGaD
Nateglinide—ABCC4—endocrine gland—brain cancer	0.000432	0.00873	CbGeAlD
Nateglinide—Tremor—Carmustine—brain cancer	0.000431	0.00893	CcSEcCtD
Nateglinide—Asthenia—Procarbazine—brain cancer	0.00043	0.00892	CcSEcCtD
Nateglinide—Hepatobiliary disease—Etoposide—brain cancer	0.00043	0.00892	CcSEcCtD
Nateglinide—Back pain—Temozolomide—brain cancer	0.00043	0.00891	CcSEcCtD
Nateglinide—PPARG—central nervous system—brain cancer	0.000429	0.00867	CbGeAlD
Nateglinide—ABCC4—head—brain cancer	0.000427	0.00862	CbGeAlD
Nateglinide—SLC15A2—midbrain—brain cancer	0.000424	0.00857	CbGeAlD
Nateglinide—Pruritus—Procarbazine—brain cancer	0.000424	0.0088	CcSEcCtD
Nateglinide—Tremor—Temozolomide—brain cancer	0.000416	0.00863	CcSEcCtD
Nateglinide—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000414	0.0134	CbGpPWpGaD
Nateglinide—SLC15A2—spinal cord—brain cancer	0.000414	0.00836	CbGeAlD
Nateglinide—Diarrhoea—Procarbazine—brain cancer	0.00041	0.00851	CcSEcCtD
Nateglinide—Dyspepsia—Hydroxyurea—brain cancer	0.000409	0.00847	CcSEcCtD
Nateglinide—SLC16A1—brain—brain cancer	0.000406	0.0082	CbGeAlD
Nateglinide—PTGS1—telencephalon—brain cancer	0.000404	0.00815	CbGeAlD
Nateglinide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000401	0.00831	CcSEcCtD
Nateglinide—Fatigue—Hydroxyurea—brain cancer	0.0004	0.0083	CcSEcCtD
Nateglinide—Dizziness—Procarbazine—brain cancer	0.000397	0.00822	CcSEcCtD
Nateglinide—Palpitations—Temozolomide—brain cancer	0.000393	0.00814	CcSEcCtD
Nateglinide—ABCC4—central nervous system—brain cancer	0.00039	0.00787	CbGeAlD
Nateglinide—SLC16A1—Cell surface interactions at the vascular wall—BSG—brain cancer	0.000388	0.0126	CbGpPWpGaD
Nateglinide—Cough—Temozolomide—brain cancer	0.000388	0.00804	CcSEcCtD
Nateglinide—Erythema multiforme—Etoposide—brain cancer	0.000386	0.00801	CcSEcCtD
Nateglinide—Vomiting—Procarbazine—brain cancer	0.000381	0.00791	CcSEcCtD
Nateglinide—Rash—Procarbazine—brain cancer	0.000378	0.00784	CcSEcCtD
Nateglinide—Dermatitis—Procarbazine—brain cancer	0.000378	0.00783	CcSEcCtD
Nateglinide—CYP2D6—brainstem—brain cancer	0.000374	0.00755	CbGeAlD
Nateglinide—UGT1A9—Irinotecan Pathway—APC—brain cancer	0.000373	0.0121	CbGpPWpGaD
Nateglinide—SLC15A2—endocrine gland—brain cancer	0.000373	0.00753	CbGeAlD
Nateglinide—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000369	0.0119	CbGpPWpGaD
Nateglinide—Immune system disorder—Etoposide—brain cancer	0.000369	0.00765	CcSEcCtD
Nateglinide—SLC15A2—head—brain cancer	0.000368	0.00743	CbGeAlD
Nateglinide—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000364	0.0118	CbGpPWpGaD
Nateglinide—Nausea—Procarbazine—brain cancer	0.000356	0.00739	CcSEcCtD
Nateglinide—Hyperhidrosis—Temozolomide—brain cancer	0.000351	0.00727	CcSEcCtD
Nateglinide—Back pain—Etoposide—brain cancer	0.000344	0.00713	CcSEcCtD
Nateglinide—PPARG—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.000342	0.0111	CbGpPWpGaD
Nateglinide—Hypersensitivity—Hydroxyurea—brain cancer	0.000342	0.00709	CcSEcCtD
Nateglinide—PPARG—brain—brain cancer	0.000341	0.00688	CbGeAlD
Nateglinide—PPARG—Nuclear Receptors—ESR2—brain cancer	0.000341	0.011	CbGpPWpGaD
Nateglinide—SLC15A2—central nervous system—brain cancer	0.000336	0.00678	CbGeAlD
Nateglinide—Asthenia—Hydroxyurea—brain cancer	0.000333	0.00691	CcSEcCtD
Nateglinide—CYP2D6—telencephalon—brain cancer	0.000332	0.0067	CbGeAlD
Nateglinide—PTGS1—pituitary gland—brain cancer	0.000329	0.00664	CbGeAlD
Nateglinide—SLC15A2—cerebellum—brain cancer	0.000328	0.00663	CbGeAlD
Nateglinide—Gastrointestinal disorder—Carmustine—brain cancer	0.000324	0.00672	CcSEcCtD
Nateglinide—ALB—brain—brain cancer	0.00032	0.00645	CbGeAlD
Nateglinide—Dyspepsia—Temozolomide—brain cancer	0.000319	0.00662	CcSEcCtD
Nateglinide—Diarrhoea—Hydroxyurea—brain cancer	0.000318	0.00659	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Temozolomide—brain cancer	0.000313	0.00649	CcSEcCtD
Nateglinide—Fatigue—Temozolomide—brain cancer	0.000313	0.00648	CcSEcCtD
Nateglinide—Cough—Etoposide—brain cancer	0.00031	0.00643	CcSEcCtD
Nateglinide—ABCC4—brain—brain cancer	0.000309	0.00625	CbGeAlD
Nateglinide—Dizziness—Hydroxyurea—brain cancer	0.000307	0.00637	CcSEcCtD
Nateglinide—Gastrointestinal pain—Carmustine—brain cancer	0.000307	0.00636	CcSEcCtD
Nateglinide—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000299	0.00968	CbGpPWpGaD
Nateglinide—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000299	0.00967	CbGpPWpGaD
Nateglinide—Abdominal pain—Carmustine—brain cancer	0.000297	0.00615	CcSEcCtD
Nateglinide—Gastrointestinal pain—Temozolomide—brain cancer	0.000297	0.00615	CcSEcCtD
Nateglinide—Vomiting—Hydroxyurea—brain cancer	0.000295	0.00612	CcSEcCtD
Nateglinide—Rash—Hydroxyurea—brain cancer	0.000293	0.00607	CcSEcCtD
Nateglinide—Dermatitis—Hydroxyurea—brain cancer	0.000292	0.00606	CcSEcCtD
Nateglinide—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00029	0.00939	CbGpPWpGaD
Nateglinide—Urticaria—Temozolomide—brain cancer	0.000288	0.00597	CcSEcCtD
Nateglinide—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000287	0.0093	CbGpPWpGaD
Nateglinide—Abdominal pain—Temozolomide—brain cancer	0.000287	0.00594	CcSEcCtD
Nateglinide—CYP3A5—endocrine gland—brain cancer	0.000283	0.00572	CbGeAlD
Nateglinide—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—BSG—brain cancer	0.000283	0.00915	CbGpPWpGaD
Nateglinide—PTGS1—spinal cord—brain cancer	0.000283	0.00571	CbGeAlD
Nateglinide—Hyperhidrosis—Etoposide—brain cancer	0.00028	0.00582	CcSEcCtD
Nateglinide—PPARG—Wnt Signaling Pathway Netpath—CDK6—brain cancer	0.00028	0.00905	CbGpPWpGaD
Nateglinide—CYP2C9—endocrine gland—brain cancer	0.000279	0.00563	CbGeAlD
Nateglinide—Hypersensitivity—Carmustine—brain cancer	0.000276	0.00573	CcSEcCtD
Nateglinide—Nausea—Hydroxyurea—brain cancer	0.000276	0.00572	CcSEcCtD
Nateglinide—Asthenia—Carmustine—brain cancer	0.000269	0.00558	CcSEcCtD
Nateglinide—PPARG—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000269	0.00871	CbGpPWpGaD
Nateglinide—Hypersensitivity—Temozolomide—brain cancer	0.000267	0.00554	CcSEcCtD
Nateglinide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000267	0.00864	CbGpPWpGaD
Nateglinide—SLC15A2—brain—brain cancer	0.000267	0.00539	CbGeAlD
Nateglinide—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000263	0.00852	CbGpPWpGaD
Nateglinide—Asthenia—Temozolomide—brain cancer	0.00026	0.0054	CcSEcCtD
Nateglinide—PPARG—Regulation of retinoblastoma protein—SKP2—brain cancer	0.000259	0.00839	CbGpPWpGaD
Nateglinide—Diarrhoea—Carmustine—brain cancer	0.000257	0.00532	CcSEcCtD
Nateglinide—Pruritus—Temozolomide—brain cancer	0.000257	0.00532	CcSEcCtD
Nateglinide—PTGS1—endocrine gland—brain cancer	0.000255	0.00514	CbGeAlD
Nateglinide—PTGS1—head—brain cancer	0.000251	0.00508	CbGeAlD
Nateglinide—Gastrointestinal disorder—Etoposide—brain cancer	0.00025	0.00519	CcSEcCtD
Nateglinide—Fatigue—Etoposide—brain cancer	0.00025	0.00519	CcSEcCtD
Nateglinide—Dizziness—Carmustine—brain cancer	0.000248	0.00515	CcSEcCtD
Nateglinide—Diarrhoea—Temozolomide—brain cancer	0.000248	0.00515	CcSEcCtD
Nateglinide—PPARG—Regulation of retinoblastoma protein—DNMT1—brain cancer	0.000244	0.00789	CbGpPWpGaD
Nateglinide—UGT1A9—PPAR Alpha Pathway—CDK4—brain cancer	0.000241	0.00781	CbGpPWpGaD
Nateglinide—Dizziness—Temozolomide—brain cancer	0.00024	0.00497	CcSEcCtD
Nateglinide—Vomiting—Carmustine—brain cancer	0.000239	0.00495	CcSEcCtD
Nateglinide—Gastrointestinal pain—Etoposide—brain cancer	0.000237	0.00492	CcSEcCtD
Nateglinide—Rash—Carmustine—brain cancer	0.000237	0.00491	CcSEcCtD
Nateglinide—Dermatitis—Carmustine—brain cancer	0.000236	0.0049	CcSEcCtD
Nateglinide—PPARG—Regulation of retinoblastoma protein—CDK6—brain cancer	0.000231	0.00748	CbGpPWpGaD
Nateglinide—Vomiting—Temozolomide—brain cancer	0.000231	0.00478	CcSEcCtD
Nateglinide—Urticaria—Etoposide—brain cancer	0.000231	0.00478	CcSEcCtD
Nateglinide—Abdominal pain—Etoposide—brain cancer	0.000229	0.00476	CcSEcCtD
Nateglinide—PTGS1—central nervous system—brain cancer	0.000229	0.00463	CbGeAlD
Nateglinide—Rash—Temozolomide—brain cancer	0.000229	0.00474	CcSEcCtD
Nateglinide—Dermatitis—Temozolomide—brain cancer	0.000228	0.00474	CcSEcCtD
Nateglinide—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000227	0.00733	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000225	0.00729	CbGpPWpGaD
Nateglinide—Nausea—Carmustine—brain cancer	0.000223	0.00462	CcSEcCtD
Nateglinide—PPARG—Circadian rythm related genes—NTRK3—brain cancer	0.000218	0.00705	CbGpPWpGaD
Nateglinide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000216	0.007	CbGpPWpGaD
Nateglinide—Nausea—Temozolomide—brain cancer	0.000215	0.00447	CcSEcCtD
Nateglinide—Hypersensitivity—Etoposide—brain cancer	0.000214	0.00443	CcSEcCtD
Nateglinide—CYP3A4—endocrine gland—brain cancer	0.000213	0.00429	CbGeAlD
Nateglinide—CYP2D6—endocrine gland—brain cancer	0.000209	0.00423	CbGeAlD
Nateglinide—Asthenia—Etoposide—brain cancer	0.000208	0.00432	CcSEcCtD
Nateglinide—CYP2D6—head—brain cancer	0.000207	0.00417	CbGeAlD
Nateglinide—Pruritus—Etoposide—brain cancer	0.000205	0.00426	CcSEcCtD
Nateglinide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000205	0.00664	CbGpPWpGaD
Nateglinide—Diarrhoea—Etoposide—brain cancer	0.000199	0.00412	CcSEcCtD
Nateglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000195	0.00632	CbGpPWpGaD
Nateglinide—UGT1A9—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000195	0.00631	CbGpPWpGaD
Nateglinide—Dizziness—Etoposide—brain cancer	0.000192	0.00398	CcSEcCtD
Nateglinide—CYP3A4—central nervous system—brain cancer	0.000192	0.00387	CbGeAlD
Nateglinide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00019	0.00614	CbGpPWpGaD
Nateglinide—UGT1A9—Biological oxidations—CYP2C9—brain cancer	0.000189	0.00612	CbGpPWpGaD
Nateglinide—CYP2D6—central nervous system—brain cancer	0.000189	0.00381	CbGeAlD
Nateglinide—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000187	0.00606	CbGpPWpGaD
Nateglinide—UGT1A9—Metapathway biotransformation—CYP2C9—brain cancer	0.000186	0.00603	CbGpPWpGaD
Nateglinide—Vomiting—Etoposide—brain cancer	0.000184	0.00383	CcSEcCtD
Nateglinide—CYP2D6—cerebellum—brain cancer	0.000184	0.00372	CbGeAlD
Nateglinide—Rash—Etoposide—brain cancer	0.000183	0.00379	CcSEcCtD
Nateglinide—Dermatitis—Etoposide—brain cancer	0.000183	0.00379	CcSEcCtD
Nateglinide—PTGS1—brain—brain cancer	0.000182	0.00368	CbGeAlD
Nateglinide—PPARG—Regulation of retinoblastoma protein—SIRT1—brain cancer	0.000176	0.0057	CbGpPWpGaD
Nateglinide—PPARG—Regulation of retinoblastoma protein—CCNE1—brain cancer	0.000174	0.00563	CbGpPWpGaD
Nateglinide—Nausea—Etoposide—brain cancer	0.000172	0.00357	CcSEcCtD
Nateglinide—PPARG—SREBP signalling—SIRT1—brain cancer	0.00017	0.00551	CbGpPWpGaD
Nateglinide—PPARG—Signaling events mediated by HDAC Class I—SIRT1—brain cancer	0.000168	0.00544	CbGpPWpGaD
Nateglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	0.000167	0.00539	CbGpPWpGaD
Nateglinide—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000159	0.00514	CbGpPWpGaD
Nateglinide—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000157	0.00507	CbGpPWpGaD
Nateglinide—UGT1A9—PPAR Alpha Pathway—CCND1—brain cancer	0.000156	0.00504	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—MPL—brain cancer	0.000156	0.00504	CbGpPWpGaD
Nateglinide—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000154	0.00499	CbGpPWpGaD
Nateglinide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000154	0.00498	CbGpPWpGaD
Nateglinide—PPARG—Wnt Signaling Pathway Netpath—APC—brain cancer	0.000152	0.00491	CbGpPWpGaD
Nateglinide—ABCC4—Ectoderm Differentiation—SHH—brain cancer	0.000151	0.00488	CbGpPWpGaD
Nateglinide—CYP2D6—brain—brain cancer	0.00015	0.00302	CbGeAlD
Nateglinide—SLC16A1—Hemostasis—S100A10—brain cancer	0.000149	0.00483	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—S100A10—brain cancer	0.000135	0.00438	CbGpPWpGaD
Nateglinide—PPARG—Regulation of retinoblastoma protein—CDK4—brain cancer	0.000133	0.00431	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000129	0.00418	CbGpPWpGaD
Nateglinide—UGT1A9—PPAR Alpha Pathway—MYC—brain cancer	0.000125	0.00405	CbGpPWpGaD
Nateglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000124	0.00401	CbGpPWpGaD
Nateglinide—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000122	0.00396	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000122	0.00394	CbGpPWpGaD
Nateglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—CDK4—brain cancer	0.000118	0.00381	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—MPL—brain cancer	0.000116	0.00376	CbGpPWpGaD
Nateglinide—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000115	0.00372	CbGpPWpGaD
Nateglinide—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000113	0.00367	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000113	0.00366	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—S100A10—brain cancer	0.000111	0.0036	CbGpPWpGaD
Nateglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	0.00011	0.00357	CbGpPWpGaD
Nateglinide—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000105	0.00341	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—BSG—brain cancer	0.000105	0.0034	CbGpPWpGaD
Nateglinide—PPARG—Wnt Signaling Pathway Netpath—CCND1—brain cancer	0.000104	0.00337	CbGpPWpGaD
Nateglinide—PPARG—Wnt Signaling Pathway Netpath—CTNNB1—brain cancer	0.000103	0.00334	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000102	0.0033	CbGpPWpGaD
Nateglinide—PPARG—Regulation of retinoblastoma protein—CDKN2A—brain cancer	0.000102	0.0033	CbGpPWpGaD
Nateglinide—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000101	0.00328	CbGpPWpGaD
Nateglinide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000101	0.00325	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—TRPC6—brain cancer	9.98e-05	0.00323	CbGpPWpGaD
Nateglinide—ABCC4—Fluoropyrimidine Activity—TP53—brain cancer	9.82e-05	0.00318	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—S100A10—brain cancer	9.64e-05	0.00312	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	9.45e-05	0.00306	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	9.39e-05	0.00304	CbGpPWpGaD
Nateglinide—PPARG—Signaling events mediated by HDAC Class I—RELA—brain cancer	9.36e-05	0.00303	CbGpPWpGaD
Nateglinide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	9.35e-05	0.00302	CbGpPWpGaD
Nateglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—RELA—brain cancer	8.67e-05	0.0028	CbGpPWpGaD
Nateglinide—PPARG—Regulation of retinoblastoma protein—CCND1—brain cancer	8.61e-05	0.00279	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.45e-05	0.00273	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	8.39e-05	0.00271	CbGpPWpGaD
Nateglinide—PPARG—Wnt Signaling Pathway Netpath—MYC—brain cancer	8.36e-05	0.0027	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—IRS2—brain cancer	8.26e-05	0.00267	CbGpPWpGaD
Nateglinide—CYP2D6—Biological oxidations—CYP2C9—brain cancer	8.17e-05	0.00264	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	8.06e-05	0.00261	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—BSG—brain cancer	7.85e-05	0.00254	CbGpPWpGaD
Nateglinide—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	7.75e-05	0.00251	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—SOD2—brain cancer	7.64e-05	0.00247	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—VAV1—brain cancer	7.48e-05	0.00242	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.26e-05	0.00235	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—SIRT1—brain cancer	7.24e-05	0.00234	CbGpPWpGaD
Nateglinide—PPARG—Signaling events mediated by HDAC Class I—STAT3—brain cancer	7.09e-05	0.00229	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TRPC6—brain cancer	6.9e-05	0.00223	CbGpPWpGaD
Nateglinide—ABCC4—Platelet degranulation—VEGFA—brain cancer	6.4e-05	0.00207	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—TRPC6—brain cancer	6.25e-05	0.00202	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.18e-05	0.002	CbGpPWpGaD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	6.1e-05	0.00197	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—SOD2—brain cancer	6.07e-05	0.00196	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—TRPC6—brain cancer	5.97e-05	0.00193	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.92e-05	0.00191	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—TRPC6—brain cancer	5.63e-05	0.00182	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—CDK4—brain cancer	5.47e-05	0.00177	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	5.46e-05	0.00177	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—RELA—brain cancer	5.42e-05	0.00175	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.34e-05	0.00173	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.31e-05	0.00172	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TRPC6—brain cancer	5.27e-05	0.00171	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.27e-05	0.00171	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—MPL—brain cancer	5.26e-05	0.0017	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CYP2C9—brain cancer	5.25e-05	0.0017	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—TRPC6—brain cancer	5.22e-05	0.00169	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—VAV1—brain cancer	5.17e-05	0.00167	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TRPC6—brain cancer	5.14e-05	0.00166	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CYP2C9—brain cancer	5.09e-05	0.00165	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—S100A10—brain cancer	5.04e-05	0.00163	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CYP2C9—brain cancer	5.02e-05	0.00162	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—CTNNB1—brain cancer	4.96e-05	0.0016	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	4.75e-05	0.00154	CbGpPWpGaD
Nateglinide—ABCC4—Ectoderm Differentiation—CTNNB1—brain cancer	4.7e-05	0.00152	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—ESR2—brain cancer	4.65e-05	0.0015	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	4.52e-05	0.00146	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—BSG—brain cancer	4.46e-05	0.00144	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—TRPC6—brain cancer	4.45e-05	0.00144	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—RELA—brain cancer	4.41e-05	0.00143	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—NOTCH2—brain cancer	4.4e-05	0.00142	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	4.36e-05	0.00141	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—BSG—brain cancer	4.33e-05	0.0014	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.33e-05	0.0014	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—STAT3—brain cancer	4.32e-05	0.0014	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—BSG—brain cancer	4.27e-05	0.00138	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—IL2—brain cancer	3.97e-05	0.00129	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	3.88e-05	0.00125	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—VAV1—brain cancer	3.85e-05	0.00125	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—IDH1—brain cancer	3.84e-05	0.00124	CbGpPWpGaD
Nateglinide—ABCC4—Ectoderm Differentiation—MYC—brain cancer	3.81e-05	0.00123	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.8e-05	0.00123	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CYP2C9—brain cancer	3.76e-05	0.00122	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—IDH1—brain cancer	3.72e-05	0.0012	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—IDH1—brain cancer	3.67e-05	0.00119	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—BSG—brain cancer	3.55e-05	0.00115	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—RELA—brain cancer	3.51e-05	0.00113	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—HES1—brain cancer	3.4e-05	0.0011	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	3.38e-05	0.00109	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—IL2—brain cancer	3.34e-05	0.00108	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—PIK3CG—brain cancer	3.28e-05	0.00106	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP2C9—brain cancer	3.23e-05	0.00105	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—BSG—brain cancer	3.2e-05	0.00104	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ENO2—brain cancer	3.04e-05	0.000982	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ENO2—brain cancer	2.94e-05	0.000952	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ENO2—brain cancer	2.9e-05	0.000938	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—VEGFA—brain cancer	2.9e-05	0.000937	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—VEGFA—brain cancer	2.84e-05	0.000918	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.78e-05	0.000899	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	2.76e-05	0.000892	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—IDH1—brain cancer	2.75e-05	0.00089	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—BSG—brain cancer	2.75e-05	0.000889	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP2C9—brain cancer	2.72e-05	0.00088	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—CDK4—brain cancer	2.67e-05	0.000862	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP2C9—brain cancer	2.64e-05	0.000853	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TP53—brain cancer	2.55e-05	0.000826	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—DNMT1—brain cancer	2.49e-05	0.000806	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—PIK3CG—brain cancer	2.45e-05	0.000791	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—IDH1—brain cancer	2.36e-05	0.000765	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—TP53—brain cancer	2.33e-05	0.000753	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TRPC6—brain cancer	2.33e-05	0.000753	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—BSG—brain cancer	2.31e-05	0.000748	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—IL2—brain cancer	2.31e-05	0.000747	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.28e-05	0.000736	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—BSG—brain cancer	2.24e-05	0.000725	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.24e-05	0.000725	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—ESR2—brain cancer	2.24e-05	0.000724	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ENO2—brain cancer	2.18e-05	0.000704	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	2.15e-05	0.000695	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—NOTCH2—brain cancer	2.12e-05	0.000686	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	2.01e-05	0.000652	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—IDH1—brain cancer	1.99e-05	0.000643	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP2C9—brain cancer	1.97e-05	0.000636	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—VEGFA—brain cancer	1.96e-05	0.000635	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—RELA—brain cancer	1.96e-05	0.000634	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—ERBB2—brain cancer	1.95e-05	0.00063	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—IDH1—brain cancer	1.93e-05	0.000623	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.93e-05	0.000623	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ENO2—brain cancer	1.87e-05	0.000605	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—SIRT1—brain cancer	1.8e-05	0.000583	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VAV1—brain cancer	1.74e-05	0.000564	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—IL2—brain cancer	1.72e-05	0.000557	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—CTNNB1—brain cancer	1.7e-05	0.000551	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP2C9—brain cancer	1.69e-05	0.000548	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—BSG—brain cancer	1.67e-05	0.000541	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ENO2—brain cancer	1.57e-05	0.000508	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.57e-05	0.000508	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ENO2—brain cancer	1.52e-05	0.000493	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	1.51e-05	0.000489	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—VEGFA—brain cancer	1.5e-05	0.000485	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—STAT3—brain cancer	1.49e-05	0.000481	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TP53—brain cancer	1.48e-05	0.00048	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—MYC—brain cancer	1.47e-05	0.000474	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—VEGFA—brain cancer	1.46e-05	0.000473	CbGpPWpGaD
Nateglinide—ALB—Metabolism—BSG—brain cancer	1.44e-05	0.000466	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—IDH1—brain cancer	1.44e-05	0.000465	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP2C9—brain cancer	1.4e-05	0.000452	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CG—brain cancer	1.39e-05	0.00045	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—EGFR—brain cancer	1.35e-05	0.000437	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CG—brain cancer	1.35e-05	0.000437	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CG—brain cancer	1.33e-05	0.00043	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	1.28e-05	0.000416	CbGpPWpGaD
Nateglinide—ALB—Metabolism—IDH1—brain cancer	1.24e-05	0.0004	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—BSG—brain cancer	1.19e-05	0.000384	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—BSG—brain cancer	1.18e-05	0.000381	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ENO2—brain cancer	1.14e-05	0.000368	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CG—brain cancer	1.11e-05	0.000358	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TP53—brain cancer	1.11e-05	0.000358	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—IDH1—brain cancer	1.02e-05	0.000331	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—IDH1—brain cancer	1.01e-05	0.000328	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.01e-05	0.000326	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CG—brain cancer	9.98e-06	0.000323	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ENO2—brain cancer	9.79e-06	0.000317	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP2C9—brain cancer	9.14e-06	0.000296	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CG—brain cancer	8.57e-06	0.000277	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.25e-06	0.000267	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ENO2—brain cancer	8.08e-06	0.000261	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ENO2—brain cancer	8.01e-06	0.000259	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IL2—brain cancer	7.79e-06	0.000252	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—BSG—brain cancer	7.77e-06	0.000251	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CG—brain cancer	7.21e-06	0.000233	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MYC—brain cancer	7.06e-06	0.000228	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CG—brain cancer	6.99e-06	0.000226	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—IDH1—brain cancer	6.68e-06	0.000216	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—brain cancer	6.62e-06	0.000214	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ENO2—brain cancer	5.28e-06	0.000171	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CG—brain cancer	5.21e-06	0.000169	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—brain cancer	5e-06	0.000162	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CG—brain cancer	4.49e-06	0.000145	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CG—brain cancer	3.71e-06	0.00012	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CG—brain cancer	3.67e-06	0.000119	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CG—brain cancer	2.42e-06	7.84e-05	CbGpPWpGaD
